GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy
Status: | Completed |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/26/2018 |
Start Date: | January 2011 |
End Date: | November 2016 |
A Randomized, Double-blind, Controlled Study to Evaluate PK, PD, Safety and Efficacy of GP2013 and Rituximab in Patients With Rheumatoid Arthritis Refractory or Intolerant to Standard DMARDs and up to Three Anti-TNF Therapies.
The purpose of this study is to determine the PK/PD, efficacy and safety of GP2013 in
patients with severe rheumatoid arthritis.
patients with severe rheumatoid arthritis.
Inclusion Criteria:
- Rheumatoid arthritis as defined by the 1987 ACR classification
- Severe active seropositive disease
- Inadequate response or intolerance to other DMARDs and anti-TNFs
- Treatment with Methotrexate
Exclusion Criteria:
- Patients with systemic manifestations of rheumatoid arthritis
- Female patients nursing
- Women of childbearing potential unless using birth control
- Active infection
- Known immunodeficiency syndrome
- Positive Hepatitis B surface antigen or antibodies to Hepatitis C
- History of cancer
Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
17
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials